TrialRadiology2017

Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study.

Raquel Perez-Lopez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.